Gut Microbiota Interactions in Osteoarthritis Management

Emerging evidence highlights a bidirectional communication between the gut microbiota and joint tissues, often termed the “gut–joint axis”. In osteoarthritis, altered microbial communities and their metabolites influence systemic and local inflammation, cartilage homeostasis and bone remodelling. Disruption of microbial diversity, or dysbiosis, can promote intestinal permeability and endotoxaemia, driving macrophage activation and synovial inflammation. Conversely, beneficial bacteria and their fermentation products, notably short-chain fatty acids, modulate immune responses, preserve cartilage matrix and attenuate joint pain. Therapeutic strategies under investigation include dietary fibres that act as prebiotics, live‐microbe probiotics, targeted small-molecule metabolites and novel nanomaterials to restore a balanced microbiota and reinforce barrier function. These interventions have shown promise in preclinical models, reducing cartilage degradation, systemic adipokine dysregulation and pain behaviours. Continued elucidation of microbial signatures and mechanistic pathways is critical to translate microbiota‐based approaches into clinical practice for osteoarthritis management.

Research from Nature Portfolio

Recent human cohort analyses have delineated specific bacterial taxa linked to knee pain and joint inflammation. Elevated Streptococcus abundance in faecal samples of osteoarthritis patients correlated with increased local macrophage infiltration and severity of knee pain, suggesting a microbial driver of synovial inflammation. Parallel animal studies have demonstrated that combined prebiotic fibre supplementation and aerobic exercise in diet‐induced obese rats completely prevented knee joint damage. This intervention normalised insulin sensitivity, leptin levels, serum endotoxin and gut microbiota composition, illustrating the capacity of lifestyle‐based modulation of microbial communities to protect joint integrity in an obesity‐associated osteoarthritis model.

Gut Microbiota Interactions in Osteoarthritis Management publication trend

The graph below shows the total number of articles in gut microbiota interactions in osteoarthritis management across all publications each year (not limited to Nature Index journals).

Technical terms

Gut microbiota: The community of microorganisms residing in the gastrointestinal tract, including bacteria, viruses and fungi, which interact with host physiology and immunity.

Dysbiosis: A state of imbalance in the gut microbial community, often characterised by reduced diversity and overrepresentation of pathogenic species.

Short-chain fatty acids (SCFAs): Metabolites produced by bacterial fermentation of dietary fibres, such as acetate, propionate and butyrate, with anti-inflammatory and barrier-protective functions.

Prebiotic: A non-digestible substrate that selectively promotes growth and activity of beneficial gut bacteria, enhancing host health.

Probiotic: Live microorganisms which, when administered in adequate amounts, confer a health benefit on the host by modulating the gut ecosystem.

Aryl hydrocarbon receptor (AhR): A ligand-activated transcription factor that mediates cellular responses to microbial metabolites and regulates inflammatory pathways.

NF-κB pathway: A key intracellular signalling cascade governing the expression of pro-inflammatory genes and inflammatory mediator production in various cell types.

References

1. Gold nanoparticles exhibit anti-osteoarthritic effects via modulating interaction of the “microbiota-gut-joint” axis. Journal of Nanobiotechnology (2024).
2. Intestinal microbiome composition and its relation to joint pain and inflammation. Nature Communications (2019).
3. Protective effect of prebiotic and exercise intervention on knee health in a rat model of diet-induced obesity. Scientific Reports (2019).
4. Indole-3-propionic acid alleviates chondrocytes inflammation and osteoarthritis via the AhR/NF-κB axis. Molecular Medicine (2023).
5. Oral Administration of Lactobacillus rhamnosus Ameliorates the Progression of Osteoarthritis by Inhibiting Joint Pain and Inflammation. Cells (2021).
6. The gut microbiota in osteoarthritis: where do we stand and what can we do?. Arthritis Research & Therapy (2021).